Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "CoE"

45 News Found

Boehringer Ingelheim India and NIPER Raebareli join forces to boost pharma innovation
R&D | February 24, 2026

Boehringer Ingelheim India and NIPER Raebareli join forces to boost pharma innovation

The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies


Roche’s Gazyva hits major milestone in rare kidney disease
Clinical Trials | February 17, 2026

Roche’s Gazyva hits major milestone in rare kidney disease

Primary membranous nephropathy is a chronic autoimmune disease that attacks the kidneys’ filtering units


Avient introduces non-PFAS GlideTech formulations for catheters
Medical Device | January 07, 2026

Avient introduces non-PFAS GlideTech formulations for catheters

GlideTech materials are available in several standard base resins and offer customization options for specific applications


Paradigm Health to acquire Flatiron’s clinical research business
News | December 07, 2025

Paradigm Health to acquire Flatiron’s clinical research business

It's an acquisition that aims at forming one of the US's largest oncology trial networks


Pfizer agrees to slash prescription drug prices for Americans
News | October 01, 2025

Pfizer agrees to slash prescription drug prices for Americans

Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%


Biocon Biologics expands insulin access in Malaysia
News | June 30, 2025

Biocon Biologics expands insulin access in Malaysia

Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served


FDA accepts supplemental Biologics License Application for Roche’s Columvi combination
Drug Approval | December 06, 2024

FDA accepts supplemental Biologics License Application for Roche’s Columvi combination

For people with relapsed or refractory diffuse large B-cell lymphoma


AstraZeneca Pharma India achieves 31% revenue growth in Q1 FY25
News | August 09, 2024

AstraZeneca Pharma India achieves 31% revenue growth in Q1 FY25

The results are an outcome of the company's focus on sustainable and profitable growth and reflects all the hard work and focus teams have put in over the years